Excision and Primary Anastomosis for Short Bulbar Strictures: Is It Safe to Change from the Transecting towards the Nontransecting Technique?

Table 3

Surgical outcome per intention-to-treat cohort (IQR: interquartile range; FFS: failure-free survival; ITT-tEPA: intention-to-treat transecting excision and primary anastomosis; ITT-ntEAP: intention-to-treat nontransecting excision and primary anastomosis; NA: not available).

	ITT-tEPA (n=101)	ITT-ntEPA (n=99)	p-value
follow-up (months); median (IQR)	122 (97-150)	33 (17-59)	<0,001
age (years); median (IQR)	50 (34-67)	44 (31-63)	0,102
stricture length (cm); median (IQR)	1,5 (1-2)	1,5 (1-2)	0,07
diabetes; n(%)	6 (5,9%)	5 (5,1%)	1
presence of suprapubic catheter; n(%)	26 (25,7%)	18 (18,2%)	0,233
operation time (minutes); median (IQR)	95 (80-110)	88 (73-100)	0,009
previous urethroplasty; n(%)	15 (14,9%)	22 (22,2%)	0,205
hospital stay (days); median (IQR)	3 (2-4)	2 (1-2)	<0,001
extravasation at first cystography; n(%)	4 (4%)	8 (8,1%)	0,248
catheterisation time (days); n(%)	14 (13-14)	9 (8-14)	<0,001
failure; n(%)	12 (11,9%)	7 (7,1%)	0,336
complications; n(%)
none	92 (91,1%)	78 (78,8%)	0,024
G1	7 (6,9%)	13 (13,1%)
G2	1 (1%)	7 (7,1%)
G3	1 (1%)	1 (1%)
Estimated failure free survival, % (standard deviation)
1y-FFS	98 (±1,4)%	96 (±2)%	0,256
3y-FFS	95 (±2,2)%	96 (±2)%
10y-FFS	87,4 (±3,7)%	NA